Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in KYMERA THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 912,498 shares of KYMR (KYMERA THERAPEUTICS INC), worth $71M as of 2025-Q4. The position was increased (++5.6% shares). KYMR represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$71M
Current Shares
912,498
Total Value Change
+$58.1M
Total Shares Change
+478,925
Other major holders of KYMR: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, BANQUE PICTET & CIE SA
Increased |
| 912,498 |
+5.6% |
| $71M |
| 0.0% |
| $78.12 |
31 |
| 2025-Q3 | Increased | 863,762 | +5.5% | $48.9M | 0.0% | $58.50 | 31 |
| 2025-Q2 | Decreased | 818,927 | -8.6% | $35.7M | 0.0% | $44.12 | 0 |
| 2025-Q1 | Increased | 896,404 | +121.5% | $24.5M | 0.0% | $29.62 | 46 |
| 2024-Q4 | Decreased | 404,667 | -5.6% | $16.3M | 0.0% | $39.32 | 0 |
| 2024-Q3 | Decreased | 428,529 | -1.2% | $20.3M | 0.0% | $48.69 | 0 |
| 2024-Q2 | Increased | 433,573 | +141.0% | $12.9M | 0.0% | $29.85 | 45 |